Submission for Office of Management and Budget (OMB) Review; Procedural Justice-Informed Alternatives to Contempt Demonstration (OMB #0970-0505), 74424-74425 [2022-26328]
Download as PDF
74424
Federal Register / Vol. 87, No. 232 / Monday, December 5, 2022 / Notices
Dated: November 29, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2022–26340 Filed 12–2–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget (OMB) Review; Procedural
Justice-Informed Alternatives to
Contempt Demonstration (OMB #0970–
0505)
Office of Child Support
Enforcement, Administration for
Children and Families, Department of
Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Office of Child Support
Enforcement (OCSE), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to add
additional data collection activities as
part of the rigorous evaluation of the
Procedural Justice-Informed
Alternatives to Contempt (PJAC)
Demonstration. The proposed revision
to conduct additional data collection is
part of a research supplement that
builds on the PJAC study to understand
the role of bias in child support program
enforcement actions.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
SUMMARY:
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: OCSE is proposing to
conduct additional data collection
activities as part of the PJAC
Demonstration. In September 2016,
OCSE issued grants to five state child
support agencies to provide alternative
approaches to the contempt process
with the goal of increasing noncustodial
parents’ compliance with child support
orders by building trust and confidence
in the child support agency and its
processes. OCSE also awarded a grant to
support a rigorous evaluation of PJAC.
The PJAC Demonstration is designed to
help grantees and OCSE to learn
whether incorporating principles of
procedural justice into child support
business practices increases reliable
child support payments, reduces
arrears, minimizes the need for
continued enforcement actions and
sanctions, and reduces the use of
contempt proceedings.
The PJAC demonstration will yield
information about the efficacy of
applying procedural justice principles
via a set of alternative services to the
current use of a civil contempt process
to address nonpayment of child support.
As a part of the evaluation, PJAC will
build evidence about disparity and bias
in the child support system, with a
focus on the use of enforcement actions
used to coerce child support payments.
The research will measure the extent to
which bias is embedded within child
support policies and practices. The
information gathered may help inform
future policy decisions to better
understand and reduce disparities
within the child support program.
The research will document
disparities and differences in treatment
by race and ethnicity, gender, and
income within the child support system
in up to three states participating in the
PJAC demonstration. Key elements of
the study include a quantitative analysis
of disparities in the initiation of a child
support case, setting of order amounts,
order modifications, and use of punitive
enforcement actions, including civil
contempt; semi-structured interviews
with staff from child support agencies
and selected partner organizations; and
separate semi-structured interviews
with study participants to learn about
their experiences with and perceptions
of bias in the child support process,
specifically in the use of enforcement
actions.
OCSE is proposing to conduct
additional data collection activities as
part of the PJAC Demonstration, which
include the following: a topic guide for
interviews about experiences of bias
with noncustodial parents and a topic
guide for interviews about experiences
of bias with child support staff and
partners.
Data collection activities that were
previously approved by OMB, following
public comment, are the staff data entry
on participant baseline information,
study Management Information Systems
(MIS) to track receipt of services, staff
and community partner interview topic
guide, the noncustodial parent
participant interview protocol, the staff
survey, the staff time study, and the
custodial parent interview protocol.
These instruments are currently in use
and this request will extend approval to
continue data collection. Supporting
materials, including burden estimates
related to approved instruments are
available at https://www.reginfo.gov/
public/do/PRAICList?ref_nbr=2022020970-013. The following burden table
includes information for the proposed
new interviews.
Respondents: Respondents for the
new data collection instruments include
study participants and child support
program staff and partners at three of
the six PJAC demonstration sites.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
ddrumheller on DSK30NT082PROD with NOTICES
Instrument
Topic list for interviews about experiences of bias with
staff and partners .............................................................
Topic guide for interviews about experiences of bias with
noncustodial parents ........................................................
VerDate Sep<11>2014
19:34 Dec 02, 2022
Jkt 259001
PO 00000
Frm 00034
Fmt 4703
Total
number of
responses per
respondent
Average
burden hours
per response
Total
burden hours
Annual
burden hours
90
1
1.5
135
45
90
1
1
90
30
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
Federal Register / Vol. 87, No. 232 / Monday, December 5, 2022 / Notices
Estimated Total Annual Burden
Hours: 75.
Authority: 42 U.S.C. 1315.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2022–26328 Filed 12–2–22; 8:45 am]
BILLING CODE 4184–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–D–3101]
Abbreviated New Drug Applications:
Pre-Submission Facility
Correspondence Related to Prioritized
Generic Drug Submissions; Draft
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a revised
draft guidance for industry entitled
‘‘ANDAs: Pre-Submission Facility
Correspondence Related to Prioritized
Generic Drug Submissions.’’ For
purposes of implementing the Generic
Drug User Fee Amendments of 2022
(GDUFA III), the Pre-Submission
Facility Correspondence (PFC) process
was revised as part of the performance
goals and program enhancements agreed
to by FDA and industry, as described in
the GDUFA Reauthorization
Performance Goals and Program
Enhancements, Fiscal Years 2023
through 2027 (GDUFA III commitment
letter). FDA assesses facility information
submitted in a PFC to inform the
Agency’s decision regarding the need
for facility inspections that support
assessment of the abbreviated new drug
application (ANDA). A complete and
accurate PFC allows the Agency to begin
the facility assessment process in
advance of the planned ANDA
submission for priority ANDAs,
allowing the Agency more time to make
preapproval inspection decisions. A
PFC meeting the conditions outlined in
the revised draft guidance will qualify
the ANDA for a shorter, 8-month
priority review goal. This revised draft
guidance describes the content, timing,
and assessment of a complete and
accurate PFC for purposes of GDUFA III.
Additionally, this revised draft guidance
provides information on the Agency’s
rationale for and current approach to
assessing a PFC and replaces the
previous draft guidance for industry,
‘‘ANDAs: Pre-Submission of Facility
ddrumheller on DSK30NT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:34 Dec 02, 2022
Jkt 259001
Information Related to Prioritized
Generic Drug Applications (PreSubmission Facility Correspondence),’’
issued in November 2017.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by March 6, 2023.
Submit either electronic or written
comments concerning the collection of
information proposed in the draft
guidance by February 3, 2023.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
74425
2017–D–3101 for ‘‘ANDAs: PreSubmission Facility Correspondence
Related to Prioritized Generic Drug
Submissions.’’ Received comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the draft guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10001 New
Hampshire Ave., Hillandale Building,
4th Floor, Silver Spring, MD 20993–
0002. Send one self-addressed adhesive
E:\FR\FM\05DEN1.SGM
05DEN1
Agencies
[Federal Register Volume 87, Number 232 (Monday, December 5, 2022)]
[Notices]
[Pages 74424-74425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for Office of Management and Budget (OMB) Review;
Procedural Justice-Informed Alternatives to Contempt Demonstration (OMB
#0970-0505)
AGENCY: Office of Child Support Enforcement, Administration for
Children and Families, Department of Health and Human Services.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Office of Child Support Enforcement (OCSE), Administration
for Children and Families (ACF), U.S. Department of Health and Human
Services (HHS), is proposing to add additional data collection
activities as part of the rigorous evaluation of the Procedural
Justice-Informed Alternatives to Contempt (PJAC) Demonstration. The
proposed revision to conduct additional data collection is part of a
research supplement that builds on the PJAC study to understand the
role of bias in child support program enforcement actions.
DATES: Comments due within 30 days of publication. OMB must make a
decision about the collection of information between 30 and 60 days
after publication of this document in the Federal Register. Therefore,
a comment is best assured of having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. You can
also obtain copies of the proposed collection of information by
emailing [email protected]. Identify all emailed requests by
the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: OCSE is proposing to conduct additional data
collection activities as part of the PJAC Demonstration. In September
2016, OCSE issued grants to five state child support agencies to
provide alternative approaches to the contempt process with the goal of
increasing noncustodial parents' compliance with child support orders
by building trust and confidence in the child support agency and its
processes. OCSE also awarded a grant to support a rigorous evaluation
of PJAC. The PJAC Demonstration is designed to help grantees and OCSE
to learn whether incorporating principles of procedural justice into
child support business practices increases reliable child support
payments, reduces arrears, minimizes the need for continued enforcement
actions and sanctions, and reduces the use of contempt proceedings.
The PJAC demonstration will yield information about the efficacy of
applying procedural justice principles via a set of alternative
services to the current use of a civil contempt process to address
nonpayment of child support. As a part of the evaluation, PJAC will
build evidence about disparity and bias in the child support system,
with a focus on the use of enforcement actions used to coerce child
support payments. The research will measure the extent to which bias is
embedded within child support policies and practices. The information
gathered may help inform future policy decisions to better understand
and reduce disparities within the child support program.
The research will document disparities and differences in treatment
by race and ethnicity, gender, and income within the child support
system in up to three states participating in the PJAC demonstration.
Key elements of the study include a quantitative analysis of
disparities in the initiation of a child support case, setting of order
amounts, order modifications, and use of punitive enforcement actions,
including civil contempt; semi-structured interviews with staff from
child support agencies and selected partner organizations; and separate
semi-structured interviews with study participants to learn about their
experiences with and perceptions of bias in the child support process,
specifically in the use of enforcement actions.
OCSE is proposing to conduct additional data collection activities
as part of the PJAC Demonstration, which include the following: a topic
guide for interviews about experiences of bias with noncustodial
parents and a topic guide for interviews about experiences of bias with
child support staff and partners.
Data collection activities that were previously approved by OMB,
following public comment, are the staff data entry on participant
baseline information, study Management Information Systems (MIS) to
track receipt of services, staff and community partner interview topic
guide, the noncustodial parent participant interview protocol, the
staff survey, the staff time study, and the custodial parent interview
protocol. These instruments are currently in use and this request will
extend approval to continue data collection. Supporting materials,
including burden estimates related to approved instruments are
available at https://www.reginfo.gov/public/do/PRAICList?ref_nbr=202202-0970-013. The following burden table includes
information for the proposed new interviews.
Respondents: Respondents for the new data collection instruments
include study participants and child support program staff and partners
at three of the six PJAC demonstration sites.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Total number Average burden
Instrument Total number of responses hours per Total burden Annual burden
of respondents per respondent response hours hours
----------------------------------------------------------------------------------------------------------------
Topic list for interviews about 90 1 1.5 135 45
experiences of bias with staff
and partners...................
Topic guide for interviews about 90 1 1 90 30
experiences of bias with
noncustodial parents...........
----------------------------------------------------------------------------------------------------------------
[[Page 74425]]
Estimated Total Annual Burden Hours: 75.
Authority: 42 U.S.C. 1315.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2022-26328 Filed 12-2-22; 8:45 am]
BILLING CODE 4184-41-P